Expression levels of novel cytokine IL-32 in periodontitis and its role in the suppression of IL-8 production by human gingival fibroblasts stimulated with porphyromonas gingivalis

Journal of Oral Microbiology

Volumn 4, Issue 2012, 2012, Pages

  Ouhara, Kazuhisa ^a,b   Kawai, Toshihisa ^b   Silva, Marcelo J B ^b   Fujita, Tsuyoshi ^a   Hayashida, Kouichi ^a   Karimbux, Nadeem Y ^c   Kajiya, Mikihito ^b   Shiba, Hideki ^a   Kawaguchi, Hiroyuki ^a   Kurihara, Hidemi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b FORSYTH INSTITUTE   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Human gingival fibroblast; Interleukin 32; Interleukin 8S; Periodontal disease; Porphyromonas gingivalis

Indexed keywords

INTERLEUKIN 32; INTERLEUKIN 8; MESSENGER RNA; NEUTRALIZING ANTIBODY; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 32; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM BASAL CELL; FEMALE; FIBROBLAST; GINGIVA FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; SQUAMOUS CELL; UPREGULATION;

EID: 84864828685     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v4i0.14832     Document Type: Article

References (33)

1. Socransky SS, Haffajee AD. Implications of periodontal microbiology for the treatment of periodontal infections. Compend Suppl 1994: S684-5, 8-93; quiz S714-7.
2. Kadowaki T, Nakayama K, Okamoto K, Abe N, Baba A, Shi Y, et al. Porphyromonas gingivalis proteinases as virulence determinants in progression of periodontal diseases. J Biochem 2000; 128: 153-9.
3. Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ, Preshaw PM. Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin Exp Immunol 2009; 156: 479-87.
4. Oshiro T, Shiotani A, Shibasaki Y, Sasaki T. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. Anat Rec 2002; 266: 218-25.
5. Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000; 106: R59-67.
6. Steffen MJ, Holt SC, Ebersole JL. Porphyromonas gingivalis induction of mediator and cytokine secretion by human gingival fibroblasts. Oral Microbiol Immunol 2000; 15: 172-80.
7. Imatani T, Kato T, Okuda K. Production of inflammatory cytokines by human gingival fibroblasts stimulated by cellsurface preparations of Porphyromonas gingivalis. Oral Microbiol Immunol 2001; 16: 65-72.
8. van Winkelhoff AJ. Antibiotics in periodontics: are we getting somewhere? J Clin Periodontol 2005; 32: 1094-5.
9. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005; 22: 131-42.
10. Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006; 65 (Suppl 3): iii61-4.
11. Dahl CA, Schall RP, He HL, Cairns JS. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 1992; 148: 597-603.
12. Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, et al. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007; 149: 480-6.
13. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006; 103: 3298-303.
14. Fujita T, Iwata T, Shiba H, Igarashi A, Hirata R, Takeda K, et al. Identification of marker genes distinguishing human periodontal ligament cells from human mesenchymal stem cells and human gingival fibroblasts. J Periodontal Res 2007; 42: 283-6.
15. Ueki Y, Lin CY, Senoo M, Ebihara T, Agata N, Onji M, et al. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 'cherubism' mice. Cell 2007; 128: 71-83.
16. Hosokawa I, Hosokawa Y, Komatsuzawa H, Goncalves RB, Karimbux N, Napimoga MH, et al. Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Clin Exp Immunol 2006; 146: 218-25.
17. Shiba H, Tsuda H, Kajiya M, Fujita T, Takeda K, Hino T, et al. Neodymium-doped yttrium-aluminium-garnet laser irradiation abolishes the increase in interleukin-6 levels caused by peptidoglycan through the p38 mitogen-activated protein kinase pathway in human pulp cells. J Endod 2009; 35: 373-6.
18. Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005; 102: 16309-14.
19. Mun SH, Kim JW, Nah SS, Ko NY, Lee JH, Kim JD, et al. Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts. Arthritis Rheum 2009; 60: 678-85.
20. Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA. IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci USA 2009; 106: 3883-8.
21. Takashiba S, Naruishi K. Gene polymorphisms in periodontal health and disease. Periodontol 2000 2006; 40: 94-106.
22. de Heens GL, van der Velden U, Loos BG. Cigarette smoking enhances T cell activation and a Th2 immune response; an aspect of the pathophysiology in periodontal disease. Cytokine 2009; 47: 157-61.
23. Smolik I, Robinson D, El-Gabalawy HS. Periodontitis and rheumatoid arthritis: epidemiologic, clinical, and immunologic associations. Compend Contin Educ Dent 2009; 30: 188-90, 92, 94 passim; quiz 98, 210.
24. Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF. The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol 2009; 24: 11-7.
25. Baba A, Kadowaki T, Asao T, Yamamoto K. Roles for Arg- and Lys-gingipains in the disruption of cytokine responses and loss of viability of human endothelial cells by Porphyromonas gingivalis infection. Biol Chem 2002; 383: 1223-30.
26. Pingel LC, Kohlgraf KG, Hansen CJ, Eastman CG, Dietrich DE, Burnell KK, et al. Human beta-defensin 3 binds to hemagglutinin B (rHagB), a non-fimbrial adhesin from Porphyromonas gingivalis, and attenuates a pro-inflammatory cytokine response. Immunol Cell Biol 2008; 86: 643-9.
27. Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan ED, et al. Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta. Cytokine 2009; 49: 171-6.
28. Colic M, Gazivoda D, Vasilijic S, Vucevic D, Lukic A. Production of IL-10 and IL-12 by antigen-presenting cells in periapical lesions. J Oral Pathol Med 39: 690-6.
29. Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Barbacane RC, Castellani ML, et al. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 2003; 86: 123-9.
30. Morandini AC, Sipert CR, Ramos-Junior ES, Brozoski DT, Santos CF. Periodontal ligament and gingival fibroblasts participate in the production of TGF-beta, interleukin (IL)-8 and IL-10. Braz Oral Res 25: 157-62.
31. Uchida Y, Shiba H, Komatsuzawa H, Takemoto T, Sakata M, Fujita T, et al. Expression of IL-1 beta and IL-8 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans. Cytokine 2001; 14: 152-61.
32. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1992; 307: 97-101.
33. Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH. Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci USA 2006; 103: 3316-21.